Shanghai Shyndec Pharmaceutical 대차 대조표 상태
재무 상태 기준 확인 6/6
Shanghai Shyndec Pharmaceutical has a total shareholder equity of CN¥15.2B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 7.1%. Its total assets and total liabilities are CN¥20.1B and CN¥4.9B respectively. Shanghai Shyndec Pharmaceutical's EBIT is CN¥1.5B making its interest coverage ratio -12.5. It has cash and short-term investments of CN¥5.6B.
주요 정보
7.1%
부채 비율
CN¥1.08b
부채
| 이자 보상 비율 | -12.5x |
| 현금 | CN¥5.64b |
| 주식 | CN¥15.19b |
| 총 부채 | CN¥4.87b |
| 총 자산 | CN¥20.07b |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
재무 상태 분석
단기부채: 600420's short term assets (CN¥11.6B) exceed its short term liabilities (CN¥4.6B).
장기 부채: 600420's short term assets (CN¥11.6B) exceed its long term liabilities (CN¥254.9M).
부채 대 자본 내역 및 분석
부채 수준: 600420 has more cash than its total debt.
부채 감소: 600420's debt to equity ratio has reduced from 46.9% to 7.1% over the past 5 years.
부채 범위: 600420's debt is well covered by operating cash flow (212.6%).
이자 보장: 600420 earns more interest than it pays, so coverage of interest payments is not a concern.